Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry

Vanessa Martelli^{1

2}, Jenna Sykes², Pierre-Régis Burgel^{3

4

5

6}, Gil Bellis^{4

7}, Adèle Coriati², Sanja Stanojevic⁸, Anne Louise Stephenson^{9

2}

Affiliations

¹ Dept of Medicine, University of Toronto, Toronto, ON, Canada.
² Adult Cystic Fibrosis Program, Division of Respirology, St Michael's Hospital, Toronto, ON, Canada.
³ Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Inserm U1016 Institut Cochin, Paris, France.
⁵ Université de Paris, Paris, France.
⁶ ERN Lung CF Network.
⁷ Institut National d'Études Démographiques, Paris, France.
⁸ Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.
⁹ Dept of Medicine, University of Toronto, Toronto, ON, Canada anne.stephenson@unityhealth.to.

PMID: 31649066
DOI: 10.1183/13993003.01667-2019

Free article

Comment

Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry

Vanessa Martelli et al. Eur Respir J. 2020.

Free article

. 2020 Jan 30;55(1):1901667.

doi: 10.1183/13993003.01667-2019. Print 2020 Jan.

Authors

Vanessa Martelli^{1

2}, Jenna Sykes², Pierre-Régis Burgel^{3

4

5

6}, Gil Bellis^{4

7}, Adèle Coriati², Sanja Stanojevic⁸, Anne Louise Stephenson^{9

2}

Affiliations

¹ Dept of Medicine, University of Toronto, Toronto, ON, Canada.
² Adult Cystic Fibrosis Program, Division of Respirology, St Michael's Hospital, Toronto, ON, Canada.
³ Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Inserm U1016 Institut Cochin, Paris, France.
⁵ Université de Paris, Paris, France.
⁶ ERN Lung CF Network.
⁷ Institut National d'Études Démographiques, Paris, France.
⁸ Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.
⁹ Dept of Medicine, University of Toronto, Toronto, ON, Canada anne.stephenson@unityhealth.to.

PMID: 31649066
DOI: 10.1183/13993003.01667-2019

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: V. Martelli has nothing to disclose. Conflict of interest: J. Sykes has nothing to disclose. Conflict of interest: P-R. Burgel reports grants and personal fees from Boehringer Ingelheim, personal fees from AstraZenaca, Chiesi, GSK, Novartis, Pfizer, Teva, Vertex and Zambon, outside the submitted work. Conflict of interest: G. Bellis has nothing to disclose. Conflict of interest: A. Coriati has nothing to disclose. Conflict of interest: S. Stanojevic has nothing to disclose. Conflict of interest: A.L. Stephenson reports grants and personal fees from Cystic Fibrosis Canada, personal fees from Vertex Pharmceuticals, outside the submitted work.

Comment on

Future trends in cystic fibrosis demography in 34 European countries.
Burgel PR, Bellis G, Olesen HV, Viviani L, Zolin A, Blasi F, Elborn JS; ERS/ECFS Task Force on Provision of Care for Adults with Cystic Fibrosis in Europe. Burgel PR, et al. Eur Respir J. 2015 Jul;46(1):133-41. doi: 10.1183/09031936.00196314. Epub 2015 Mar 18. Eur Respir J. 2015. PMID: 25792639

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Medical
- Genetic Alliance
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry

Affiliations

Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical